A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 848,235 shares of GILD stock, worth $76.5 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
848,235
Previous 848,235 -0.0%
Holding current value
$76.5 Million
Previous $71.1 Million -0.0%
% of portfolio
0.22%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$66.59 - $83.99 $4.93 Million - $6.22 Million
74,063 Added 9.57%
848,235 $71.1 Million
Q2 2024

Jul 29, 2024

SELL
$63.15 - $72.88 $26.2 Million - $30.2 Million
-414,189 Reduced 34.85%
774,172 $53.1 Million
Q1 2024

Apr 25, 2024

SELL
$71.58 - $87.29 $21.7 Million - $26.4 Million
-302,892 Reduced 20.31%
1,188,361 $87 Million
Q4 2023

Jan 30, 2024

BUY
$73.27 - $83.09 $5.41 Million - $6.13 Million
73,824 Added 5.21%
1,491,253 $121 Million
Q3 2023

Oct 25, 2023

SELL
$73.94 - $80.67 $1.87 Million - $2.04 Million
-25,271 Reduced 1.75%
1,417,429 $106 Million
Q2 2023

Aug 07, 2023

BUY
$76.01 - $86.7 $43.8 Million - $49.9 Million
575,842 Added 66.43%
1,442,700 $111 Million
Q1 2023

May 08, 2023

BUY
$77.31 - $88.08 $3.11 Million - $3.55 Million
40,248 Added 4.87%
866,858 $71.9 Million
Q4 2022

Feb 01, 2023

BUY
$62.32 - $89.47 $4.71 Million - $6.76 Million
75,606 Added 10.07%
826,610 $71 Million
Q3 2022

Nov 09, 2022

BUY
$59.54 - $68.01 $754,133 - $861,414
12,666 Added 1.72%
751,004 $46.3 Million
Q2 2022

Aug 09, 2022

SELL
$57.72 - $65.01 $2.83 Million - $3.19 Million
-49,013 Reduced 6.23%
738,338 $45.6 Million
Q1 2022

Apr 21, 2022

BUY
$57.92 - $72.58 $3.34 Million - $4.19 Million
57,698 Added 7.91%
787,351 $46.8 Million
Q4 2021

Feb 01, 2022

BUY
$64.88 - $73.64 $2.49 Million - $2.83 Million
38,431 Added 5.56%
729,653 $53 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $3.29 Million - $3.55 Million
48,650 Added 7.57%
691,222 $48.3 Million
Q2 2021

Jul 30, 2021

BUY
$63.47 - $69.35 $3.23 Million - $3.52 Million
50,827 Added 8.59%
642,572 $44.2 Million
Q1 2021

May 03, 2021

SELL
$60.0 - $68.46 $5.17 Million - $5.9 Million
-86,180 Reduced 12.71%
591,745 $38.2 Million
Q4 2020

Jan 28, 2021

BUY
$56.65 - $64.55 $2.48 Million - $2.82 Million
43,740 Added 6.9%
677,925 $39.5 Million
Q3 2020

Nov 06, 2020

BUY
$62.1 - $78.08 $2.27 Million - $2.85 Million
36,532 Added 6.11%
634,185 $40.1 Million
Q2 2020

Jul 28, 2020

BUY
$72.34 - $84.0 $545,588 - $633,528
7,542 Added 1.28%
597,653 $46 Million
Q1 2020

May 06, 2020

BUY
$62.63 - $80.22 $456,322 - $584,482
7,286 Added 1.25%
590,111 $44.1 Million
Q4 2019

Jan 21, 2020

SELL
$61.62 - $67.78 $15.5 Million - $17.1 Million
-252,321 Reduced 30.21%
582,825 $37.9 Million
Q3 2019

Oct 18, 2019

BUY
$62.51 - $69.0 $1.12 Million - $1.24 Million
17,924 Added 2.19%
835,146 $52.9 Million
Q2 2019

Jul 30, 2019

BUY
$61.87 - $69.38 $1.93 Million - $2.16 Million
31,162 Added 3.96%
817,222 $55.2 Million
Q1 2019

Apr 29, 2019

BUY
$62.53 - $70.05 $4.22 Million - $4.73 Million
67,505 Added 9.39%
786,060 $51.1 Million
Q4 2018

Jan 25, 2019

SELL
$60.54 - $79.0 $139,605 - $182,174
-2,306 Reduced 0.32%
718,555 $44.9 Million
Q3 2018

Nov 09, 2018

SELL
$71.28 - $78.92 $2.06 Million - $2.28 Million
-28,866 Reduced 3.85%
720,861 $55.7 Million
Q2 2018

Aug 06, 2018

BUY
$64.88 - $75.68 $12.2 Million - $14.3 Million
188,646 Added 33.62%
749,727 $53.1 Million
Q1 2018

May 03, 2018

BUY
$72.84 - $88.8 $18.2 Million - $22.2 Million
250,336 Added 80.56%
561,081 $42.3 Million
Q4 2017

Jan 31, 2018

BUY
$71.15 - $83.52 $48,097 - $56,459
676 Added 0.22%
310,745 $22.3 Million
Q3 2017

Nov 08, 2017

BUY
$72.11 - $85.47 $22.4 Million - $26.5 Million
310,069
310,069 $25.1 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.